An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab)

NCT ID: NCT01392001

Last Updated: 2016-11-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

322 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-03-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study will evaluate the glucocorticoid sparing effect after 12 months of treatment with RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthritis. Data will be collected for 12 months after the initiation of treatment with RoActemra/Actemra from patients who had been on treatment with \>5 mg prednisone or equivalent for at least 3 months .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients, \>/= 18 years of age
* Patients with rheumatoid arthritis for whom the rheumatologist decided to introduce RoActemra
* Patients taking more than 5 mg/day of oral prednisone (or equivalent) for at least 3 months

Exclusion Criteria

* Participation in a clinical trial in rheumatoid arthritis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Abbeville, , France

Site Status

Agen, , France

Site Status

Aix-en-Provence, , France

Site Status

Aix-les-Bains, , France

Site Status

Alençon, , France

Site Status

Amiens, , France

Site Status

Amiens, , France

Site Status

Angers, , France

Site Status

Argenteuil, , France

Site Status

Auch, , France

Site Status

Aulnay-sous-Bois, , France

Site Status

Avignon, , France

Site Status

Bayonne, , France

Site Status

Belfort, , France

Site Status

Belley, , France

Site Status

Berck, , France

Site Status

Besançon, , France

Site Status

Blois, , France

Site Status

Bobigny, , France

Site Status

Bois-Colombes, , France

Site Status

Bondy, , France

Site Status

Bordeaux, , France

Site Status

Brest, , France

Site Status

Caen, , France

Site Status

Cahors, , France

Site Status

Cahors, , France

Site Status

Cambrai, , France

Site Status

Cannes, , France

Site Status

Carcassonne, , France

Site Status

Chambray-lès-Tours, , France

Site Status

Clermont-Ferrand, , France

Site Status

Compiègne, , France

Site Status

Corbeil-essones, , France

Site Status

Corbeil-Essonnes, , France

Site Status

Dijon, , France

Site Status

Dole, , France

Site Status

Druex, , France

Site Status

Évian-les-Bains, , France

Site Status

Évreux, , France

Site Status

Évry, , France

Site Status

Fréjus, , France

Site Status

Gap, , France

Site Status

Gleizé, , France

Site Status

La Roche-sur-Yon, , France

Site Status

Laon, , France

Site Status

Lavaur, , France

Site Status

Le Coudray, , France

Site Status

Le Kremlin-Bicêtre, , France

Site Status

Libourne, , France

Site Status

Liévin, , France

Site Status

Lille, , France

Site Status

Limoges, , France

Site Status

Lomme, , France

Site Status

Lorient, , France

Site Status

Lyon, , France

Site Status

Lyon, , France

Site Status

Lyon, , France

Site Status

Lyon, , France

Site Status

Maisons-Laffitte, , France

Site Status

Mandelieu-la-Napoule, , France

Site Status

Marseille, , France

Site Status

Marseille, , France

Site Status

Marseille, , France

Site Status

Marseille, , France

Site Status

Marseille, , France

Site Status

Meaux, , France

Site Status

Metz-Tessy, , France

Site Status

Montauban, , France

Site Status

Montpellier, , France

Site Status

Morlaix, , France

Site Status

Moulins, , France

Site Status

Mulhouse, , France

Site Status

Nanterre, , France

Site Status

Nantes, , France

Site Status

Narbonne, , France

Site Status

Nice, , France

Site Status

Niort, , France

Site Status

Nîmes, , France

Site Status

Paris, , France

Site Status

Paris, , France

Site Status

Paris, , France

Site Status

Paris, , France

Site Status

Paris, , France

Site Status

Paris, , France

Site Status

Perpignan, , France

Site Status

Pierre-Bénite, , France

Site Status

Poissy, , France

Site Status

Pontoise, , France

Site Status

Reims, , France

Site Status

Rodez, , France

Site Status

Roubaix, , France

Site Status

Saint-Chamond, , France

Site Status

Saint-Flour, , France

Site Status

Saint-Mandé, , France

Site Status

Saint-Nazaire, , France

Site Status

Saint-Priest-en-Jarez, , France

Site Status

Saint-Quentin, , France

Site Status

Salon-de-Provence, , France

Site Status

Ste Maxime, , France

Site Status

Suresnes, , France

Site Status

Thionville, , France

Site Status

Toulon, , France

Site Status

Toulon, , France

Site Status

Toulon, , France

Site Status

Toulon, , France

Site Status

Toulouse, , France

Site Status

Toulouse, , France

Site Status

Toulouse, , France

Site Status

Tourcoing, , France

Site Status

Valenciennes, , France

Site Status

Vandœuvre-lès-Nancy, , France

Site Status

Vannes, , France

Site Status

Vienne, , France

Site Status

Villefranche-sur-Saône, , France

Site Status

Villeurbanne, , France

Site Status

Vlleneuve Sur Lot, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ML25634

Identifier Type: -

Identifier Source: org_study_id